HOME >> MEDICINE >> NEWS
Hispanic and young children with kidney disease likely to be short

Children with chronic kidney disease who are very young and/or Hispanic have a greater chance of being shorter than other youngsters, according to a study done in part by the University of Alberta.

The study, which drew its findings from patient information gathered by the North American Pediatric Renal Transplant Cooperative Studies, revealed that age, race, the cause of the kidney failure and the amount of residual kidney function were associated with short stature in children with renal kidney disease.

The data of 5,615 child patients registered in a chronic renal failure registry between 1994 and 2004 was reviewed by Dr. Verna Yiu, an associate professor of pediatrics at the University of Alberta in Edmonton, Canada and fellow researchers from the University of Texas Southwestern Medical Centre, the Children's Medical Centre of Dallas, University of North Carolina and the EMMES Corporation.

The results were published recently in Pediatric Nephrology.

Of the more than 5,600 patients studied, 36.9 per cent had impaired height growth. Of those, 44.4 per cent were Hispanic, 36.1 per cent were Caucasian and 31.9 per cent were black. Younger children aged zero to 12 years also had lower height growth than children 12 and older. As well, children with congenital renal disease, as opposed to those who acquired the disease, had the lowest rate of height growth. Overall, more than one-third of children with kidney disease met the criteria for short stature.

The researchers are unsure as to why growth is delayed for the first two years of life in children with kidney disease, but believe nutrition and the body's losses of electrolytes play roles.

Ethnicity also appeared to play a role, though standardized norms for height may not take into account natural height differences among ethnic groups, Yiu said. The majority of children in the study with acquired renal disease appeared to be black (39 per cent) ver
'"/>

Contact: Bev Betkowski
beverly.betkowski@ualberta.ca
780-492-3808
University of Alberta
22-Aug-2006


Page: 1 2

Related medicine news :

1. Hispanic drug use rises in US culture
2. Survey reveals misperceptions about Alzheimers among African-American and Hispanic caregivers
3. NYPD targets black, Hispanic and poor neighborhoods for arrests for smoking marijuana in public
4. Hispanic and African American adults are uninsured at rates 1 1/2 to three times higher than whites
5. Medical Spanish course helps physician assistants examine, communicate with Hispanic patients
6. Hispanics and blacks with melanoma more likely to be diagnosed at a later stage
7. Non-Hispanic blacks have best hearing in US, new study shows
8. Hispanic 3-year-olds more likely to be obese than black or white children
9. Findings on obesity among preschoolers, post partum depression among Hispanic women and more
10. Skin disease common among Hispanic farmworkers in North Carolina, research shows
11. More black, Hispanic parents dissatisfied with health care for special needs children

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Hispanic and young children with kidney disease likely short

(Date:6/19/2013)... treating stroke victims has been "time equals brain." That,s because ... a drug that dissolves the stroke-causing blood clot can make ... or lost. , But specific information has been ... drug known as a tissue plasminogen activator, or tPA ... most common type of stroke. , Now, a ...
(Date:6/19/2013)... Loyola University Chicago Niehoff School of Nursing researcher has ... Vitamin D can improve mood in women with diabetes ... whether vitamin D supplementation can reduce blood pressure and ... is from the National Institute of Nursing Research at ... M. Penckofer, PhD, RN and colleagues hypothesize that women ...
(Date:6/19/2013)... 19, 2013 AquaPrint Solutions in Thomson, IL ... Grub with a newly-designed Harley Davidson motorcycle gas tank. A ... Solutions with an idea of taking a split tank motorcycle ... and transforming it into a work of art. , ... Grub several toilet seats that had been dipped in a ...
(Date:6/19/2013)... FL (PRWEB) June 19, 2013 Fit Body ... Andrea Laing recently held a charity boot camp in order ... fibrosis. The fitness boot camp franchise hosted the ... to 11 a.m. with 75 boot camp participants and collected ... charity boot camp marks the second fundraiser held for Orlando ...
(Date:6/19/2013)... Salt Lake City, UT (PRWEB) June 19, 2013 ... their expanded BRCA1 and BRCA2 testing service , ... genes. Analysis is available individually, or as part of ... up to seventeen additional genes with known links to ... TP53, CDK4, STK11, SMAD4, BMPR1A, CDH1, MET, FH, FLCN, ...
Breaking Medicine News(10 mins):Health News:Timely treatment after stroke is crucial, UCLA researchers report 2Health News:Timely treatment after stroke is crucial, UCLA researchers report 3Health News:Loyola receives $1.5 million grant to study vitamin D for diabetes and depression 2Health News:AquaPrint Solutions Transforms Harley Davidson Gas Tank into a Work Of Art for Poopy’s Pub & Grub 2Health News:Fit Body Boot Camp in Orlando Held Successful “Brent Can Breathe” Charity Boot Camp with Proceeds Going to Support Orlando Local Brent Snyder with Cystic Fibrosis 2Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 2Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 3
(Date:6/19/2013)... June 19, 2013   Voices Against Brain Cancer ... cure for brain cancer, today announced that it has ... support the clinical investigation of Toca 511 & Toca ... glioma brain cancer (Grade 3 or Grade 4).  Tocagen ... for advanced cancer, with an initial focus on brain ...
(Date:6/19/2013)... MUMBAI, India , June 19, ... Book Bureau has recently added DrugPatentWatch ... Databases. ( http://www.bharatbook.com/drugpatentwatch-tour.pdf ) ... DrugPatentWatch provides comprehensive information on pharmaceutical, ... value-added information supports the critical business ...
(Date:6/19/2013)... Nektar Therapeutics (Nasdaq: NKTR ) today announced ... for NKTR-181, a first-in-class, opioid analgesic molecule with ... rate of entry is designed to reduce the euphoria that ... opioid analgesics. 1 In the study data being presented ... "drug liking" and "feeling high" scores and had highly statistically ...
Breaking Medicine Technology:Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Drug Patent Watch 2Drug Patent Watch 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9
Cached News: